Have a personal or library account? Click to login
Retrospective Cohort Study Comparing Efficacy and Safety of Pharmacological Intervention and Phototherapy in Moderate to Severe Psoriasis Patients in a Real-World Setting Cover

Retrospective Cohort Study Comparing Efficacy and Safety of Pharmacological Intervention and Phototherapy in Moderate to Severe Psoriasis Patients in a Real-World Setting

Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
Volume 78 (2024): Issue 2 (April 2024)
By: Ilona Hartmane,  Ingmars Mikažāns,  Iveta Ivdra,  Vanda Bondare-Ansberga,  Irena Teterina and  Elga Bataraga  
Open Access
|Apr 2024

Authors

Ilona Hartmane

ilona.hartmane@rsu.lv

Latvia
Department of Dermatology and Venereology, Rīga Stradiņš University, Latvia

Ingmars Mikažāns

Latvia
Department of Dermatology and Venereology, Rīga Stradiņš University, Latvia

Iveta Ivdra

Latvia
Department of Dermatology and Venereology, Rīga Stradiņš University, Latvia

Vanda Bondare-Ansberga

Latvia
Department of Dermatology and Venereology, Rīga Stradiņš University, Latvia

Irena Teterina

Department of Pharmacology, Rīga Stradiņš University, Latvia

Elga Bataraga

Department of Dermatology and Venereology, Rīga Stradiņš University, Latvia
DOI: https://doi.org/10.2478/prolas-2024-0021 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Journal RSS Feed
Language: English
Page range: 141 - 146
Submitted on: Feb 28, 2023
|
Accepted on: Jan 9, 2024
|
Published on: Apr 29, 2024
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
Th 17 pathway,
combined treatment,
Nb-UVB,
T cells,
immunology
Related subjects:
General interest,
Mathematics,
General mathematics

© 2024 Ilona Hartmane, Ingmars Mikažāns, Iveta Ivdra, Vanda Bondare-Ansberga, Irena Teterina, Elga Bataraga, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 78 (2024): Issue 2 (April 2024)Next article